Alia Lutz
BSN, RN
BSN, RN
RN, BSN, BA
BA, BSN, RN, CPAN
BA, BSN, RN, CPAN
RN, BSN
BSN, RN
MSN-NE, RN
MSN-NE, RN
MSN-NE, RN
RN, BSN, IBCLC
RN, BSN, IBCLC
RN, BSN, IBCLC
BA, BSN, RN, CPAN
RN, BSN, IBCLC
Healthcare providers face many difficulties when prescribing controlled substances for management of acute and chronic pain, anxiety disorder, and attention deficit hyperactivity disorder (ADHD). The pressure to adequately treat patients suffering from these conditions, coupled with current public health problems such as rising drug overdose rates, creates a major dilemma for healthcare providers. Determining which patients could benefit from the prescription of controlled substances and which patients may suffer adverse consequences by taking these medications is not always easy.
The goal of this course is to educate healthcare providers on methods to safely and responsibly prescribe controlled substances to patients.
MSN, RN-BC
PharmD, MSLIS
RN, MSN
RN, MSN
BSN, RN
BSN, RN
RN, BSN
RN, BSN
MSN-NE, RN
MSN-NE, RN
BSN, RN
BSN, RN
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.